IR-TPM (Topamax)
FWA00000312-10
Phase 2 small_molecule terminated
Quick answer
IR-TPM (Topamax) for Migraine is a Phase 2 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Migraine
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated